1,390 results on '"Saussez, Sven"'
Search Results
2. ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy
Catalog
Books, media, physical & digital resources
3. Personalized medicine in olfactory testing: perspectives to improve patient compliance to psychophysical tests
4. Comparison of prevalence and evolution of COVID-19 olfactory disorders in patients infected by D614 (wild) and B.1.1.7. Alpha variant: a brief report
5. Impact of Acid, Weakly Acid and Alkaline Laryngopharyngeal Reflux on Voice Quality
6. Platelet-rich plasma injection in the olfactory clefts of COVID-19 patients with long-term olfactory dysfunction
7. Effectiveness of olfactory training in COVID-19 patients with olfactory dysfunction: a prospective study
8. Usefulness, acceptation and feasibility of electronic medical history tool in reflux disease
9. Xerostomia, sticky saliva and dysphonia
10. Laryngopharyngeal reflux may be acute, recurrent or chronic disease: preliminary observations
11. Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck cancer with lung metastasis: a retrospective study
12. Proof-of-concept of a new FFP2 mask adapted to Otolaryngological practice in pandemic: a prospective study
13. Acoustic measurements are useful therapeutic indicators of patients with dysphonia-related to reflux
14. Bufalin for an innovative therapeutic approach against cancer
15. Effectiveness and safety of PRP on persistent olfactory dysfunction related to COVID-19
16. Gustatory Dysfunction: A Highly Specific and Smell-Independent Symptom of COVID-19
17. Features of Mild-to-Moderate COVID-19 Patients With Dysphonia
18. Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study
19. Validity and reliability of a french version of the olfactory disorders questionnaire
20. Anosmia: an evolution of our understanding of its importance in COVID-19 and what questions remain to be answered
21. Are the Acoustic Measurements Reliable in the Assessment of Voice Quality? A Methodological Prospective Study
22. Laryngopharyngeal reflux: The microbiota theory
23. More that ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival
24. Mucosal antibody response and SARS-CoV-2 shedding in patients with COVID-19 related olfactory dysfunction.
25. The study of olfactory dysfunction in SARS-CoV-2 variants
26. Post-COVID-19 Dysphonia may have Several Origins
27. Screening Evaluation for Laryngopharyngeal Reflux Disease
28. Specific Therapy of Olfactory Disorders in COVID-19 Patients is Essential for the Prevention of Long-term Dysfunction
29. Sinus and anterior skull base surgery during the COVID-19 pandemic: systematic review, synthesis and YO-IFOS position
30. Impact of subspecialty training on management of laryngopharyngeal reflux: results of a worldwide survey
31. Reflux clinic: proof-of-concept of a Multidisciplinary European Clinic
32. Validity and Reliability of the Reflux Sign Assessment‐10 (RSA‐10).
33. Bufalin Suppresses Head and Neck Cancer Development by Modulating Immune Responses and Targeting the β-Catenin Signaling Pathway.
34. Mortality Rate and Predictors among Patients with COVID-19 Related Acute Respiratory Failure Requiring Mechanical Ventilation: A Retrospective Single Centre Study
35. Surgical, clinical and functional outcomes of transoral robotic surgery for supraglottic laryngeal cancers: A systematic review
36. Systematic review of international guidelines for tracheostomy in COVID-19 patients
37. Reflux and dental disorders in the pediatric population: A systematic review
38. Voice Quality as Therapeutic Outcome in Laryngopharyngeal Reflux Disease: A Prospective Cohort Study
39. Digestive Biomarkers of Laryngopharyngeal Reflux: A Preliminary Prospective Controlled Study
40. Impact of COVID-19 Lockdown on Stress and Antireflux Diet Adherence of Patients with Laryngopharyngeal Reflux: Our Experience on 32 patients.
41. Mucosal antibody response and SARS‐CoV‐2 shedding in patients with COVID‐19 related olfactory dysfunction
42. ACE2 & TMPRSS2 Expressions in Head & Neck Tissues: A Systematic Review
43. Patterns of Gustatory Recovery in Patients Affected by the COVID-19 Outbreak
44. Validity and reliability of a French version of M.D. Anderson Dysphagia Inventory
45. Ethyl alcohol threshold test: a fast, reliable and affordable olfactory Assessment tool for COVID-19 patients
46. Patients with acid, high-fat and low-protein diet have higher laryngopharyngeal reflux episodes at the impedance-pH monitoring
47. In reply to: IL-6 serum level and olfactory dysfunction severity in COVID-19: correspondence
48. Impact of Laryngopharyngeal Reflux on Subjective, Aerodynamic, and Acoustic Voice Assessments of Responder and Nonresponder Patients
49. Voice Quality and Orofacial Strength as Outcome of Levodopa Effectiveness in Patients with Early Idiopathic Parkinson Disease: A Preliminary Report
50. The Dubai Definition and Diagnostic Criteria of Laryngopharyngeal Reflux: The IFOS Consensus.
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.